Iron Deficiency Anemia of Pregnancy Clinical Trial
Official title:
Iron Bisglycinate Chelate or Ferrous Fumarate in Treatment of Iron Deficiency Anemia in Pregnant Women
Anemia in pregnancy is defined by the World Health Organization as hemoglobin levels of ≤ 11
g/dl. Globally, a prevalence rate of 38% was estimated by the World Health Organization for
pregnant women.Treatment of iron deficiency anemia during pregnancy remains a main public
health issue. Oral iron salts have been recommended for treatment of iron deficiency anemia
e.g. ferrous fumarate. Increasing the dose of ferrous fumarate will subsequently increase the
bioavailability of iron preparation, however it also increases the frequency of
gastrointestinal tract side effects e.g. nausea, constipation, diarrhea, flatulence, and
black stained stools. Besides, the increased bioavailable ferrous fumarate may decrease by
many foods and / or chelating drugs in the gastrointestinal tract which interfere with its
absorption leading to variability in the hemoglobin correction during the treatment.
Ferrous bisglycinate is an iron amino acid chelate. It is formed by reaction of ferrous iron
with two molecules of the amino acid glycine by a covalent bound in a process called
chelation. Ferrous bisglycinate is claimed to have better patient compliance because of fewer
gastrointestinal tract side effects. It is also claimed that ferrous bisglycinate improves
iron absorption, storage and increase hemoglobin level better than the conventionally used
iron salts.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03456258 -
Lactoferrin Versus Ferrous Sulphate for the Treatment of Iron Deficiency Anemia During Pregnancy
|
N/A | |
| Not yet recruiting |
NCT04074707 -
Defining a Dosing Regimen With Maximal Absorption for Oral Iron Supplementation During Pregnancy
|
N/A | |
| Completed |
NCT03481790 -
Lactoferrin Versus Ferrous Sulphate for Treatment of Iron Deficiency Anaemia During Pregnancy
|
Phase 2 | |
| Terminated |
NCT04594070 -
Daily Versus Alternate Day Iron Supplementation for the Treatment of Iron Deficiency Anemia in Pregnancy
|
Phase 4 | |
| Completed |
NCT03706638 -
Daily vs Intermittent Iron Therapy in Pregnancy
|
N/A | |
| Recruiting |
NCT06366698 -
Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia
|
Phase 3 | |
| Not yet recruiting |
NCT03484845 -
Lactoferrin Versus Ferrous Fumarate for Treatment of Mild to Moderate Iron Deficiency Anemia During Pregnancy
|
Phase 1/Phase 2 | |
| Recruiting |
NCT03961074 -
Iron Deficiency Anemia Among Chinese Pregnant Women: a Multi-center Prospective Cohort Study
|
||
| Recruiting |
NCT05804071 -
Analysis of the Effect of Iron Supplements on Iron Deficiency Anemia in Pregnancy
|
Phase 4 | |
| Recruiting |
NCT04008147 -
Hepcidin and Glucose Metabolism
|
N/A | |
| Completed |
NCT03188445 -
Intravenous Iron Isomaltoside Versus Oral Iron Supplementation for Treatment of Iron Deficiency in Pregnancy.
|
Phase 4 | |
| Completed |
NCT05157828 -
Iron Deficiency Anaemia in Pregnant Patients Presenting for Antenatal Care
|
||
| Active, not recruiting |
NCT05545527 -
Neuroimaging Ancillary Study
|
||
| Completed |
NCT05725278 -
Impact Evaluation of Triggerise's Tiko Platform
|
N/A | |
| Completed |
NCT02005588 -
Treatment of Iron Deficiency Anemia With Pregnancy
|
Phase 0 | |
| Completed |
NCT03657433 -
Intravenous Infusions of Ferumoxytol Compared to Oral Ferrous Sulfate for the Treatment of Anemia in Pregnancy
|
Phase 3 | |
| Completed |
NCT04976179 -
Iron Infusion Into a Vein Compared to Iron Tablet Taken by Mouth for Treating Iron Deficiency Anemia in Pregnancy (IVON)
|
Phase 3 | |
| Completed |
NCT03438227 -
Intravenous Iron for Iron-deficiency Anemia in Pregnancy: a Randomized Controlled Trial
|
Phase 4 | |
| Available |
NCT05151679 -
Chelated Oral Iron Versus Intravenous Iron Sucrose for Treatment of Iron Deficiency Anemia Late in Pregnancy
|